Select Page

Clinical Outcomes Assessment Discussion- Session #2

Virtual

Join C-Path and the FDA in a discussion of clinical outcome assessments (COAs) versus clinical endpoints and how these findings will be used to advance additional research and to support future clinical trials. There will also be a Q&A session. To register and submit questions in advance of the discussion, visit: https://c-path-org.zoom.us/webinar/register/WN_KYeJlRqkRYK2cWj7z36Cfw#/registration. Please contact Thomas Hart, […]

Free

C-Path’s Global Impact Conference

Hello C-Path Community, As we hurdle through summer, it’s already time to finalize plans for fall. The inaugural C-Path Global Impact Conference, #CGIC2024, taking place from September 9-11 in Washington, D.C., is the conference that drug developers and industry stakeholders cannot afford to miss. With highlights from all key activities across C-Path's ever-expanding portfolio, which is dedicated to […]

Advanced modelling of neuromuscular diseases and therapeutics

Virtual

Join this webinar to explore innovative, multidisciplinary approaches in disease modeling, drug testing, and tissue engineering using advanced in vitro systems. Dr. Francesco Saverio Tedesco will present cutting-edge examples, including the development of advanced muscle models for studying muscular dystrophies and designing more efficient, targeted therapies for neuromuscular diseases. Attendees will also gain insight into […]

Free

CP-RND AMP for ALS Public-Private Partnership (PPP)

Dear Advocates and Community Members, We’re excited to invite you to an upcoming virtual forum to provide an update on the Critical Path for Rare Neurodegenerative Disease (CP-RND) AMP for ALS Public-Private Partnership (PPP) and its progress toward accelerating new treatments for ALS. This session, our next installment of the continuing series offering a chance for feedback and […]

Free